Recent Research from the ODPRN

Association between angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and suicide

This study examines the association between suicide and exposure to angiotensin receptor blockers and angiotensin-converting enzyme inhibitors.

Ontario Prescription Opioid Tool: Update July 2019

This tool allows public access to data related to indicators for opioid prescribing in the province. It has been updated to include data up to March 2019 (April 2019 for naloxone) and two new indicators to capture individuals newly dispensed a prescription opioid for pain or opioid agonist therapy.

Association of mirabegron with the risk of arrhythmia in adult patients 66 years or older: A population-based cohort study

This study evaluates the risk of cardiac arrhythmias and other cardiovascular adverse events in older adults receiving mirabegron prescribed to treat overactive bladder.

The Opioid Mortality Surveillance Report: Analysis of opioid-related deaths in Ontario July 2017-June 2018

This report aims to advance understanding of the current rise of opioid-related deaths, as well as inform public health practice and system planning that addresses opioid-related harms in the province.

Additional Resources

Please note that this report is NOT COMPLETE and is still in progress. Click below if you would like to continue.